The key will be crafting the right cocktail of medications, testing additional drugs in combination with the antiviral remdesivir, COVID-19 researchers told Business Insider.
Remdesivir's use should help free up hospital beds, intensive care units, and ventilators as patients recover faster on the drug. But the real advantage will be its potential to serve as a backbone in combination studies, Gold said. "Those are critical trials, and I think will be coming in the relatively near term," said Badley, who chairs Mayo's COVID-19 research task force.Remdesivir will be tested in combination with an arthritis drug
Bell said he is most excited about combination trials where each of the drugs can treat distinct phases of the disease.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »
ソース: USATODAY - 🏆 100. / 63 続きを読む »